Glibenclamide has been shown to bind more efficiently to the ischemic hemisphere.

One class of these domains was shown to bind selectively to phosphatidylinositol 3-phosphate.

Ephrin-A5 has also been shown to bind to the EphB2 receptor.

Similarly, the glycosylation has been shown to bind to growth factors.

MUC1 cytoplasmic tail has been shown to bind to p53.

However, the proteins were shown to bind Ca +.

Morphine was the first chemical shown to bind to mu receptors.

The C2 domain was first shown to bind to calcium in synaptotagmin-1.

Additionally, it has been shown to bind Mad2 and Mad3.

Leflunomide has been shown to bind in this tunnel.